Novel Arylsulfonylhydrazones as Breast Anticancer Agents Discovered by Quantitative Structure-Activity Relationships

Novel Arylsulfonylhydrazones as Breast Anticancer Agents Discovered by Quantitative Structure-Activity Relationships

Breast cancer (BC) is the second leading cause of cancer death in women, with more than 600,000 deaths annually. Despite the progress that has been made in early diagnosis and treatment of this disease, there is still a significant need for more effective drugs with fewer side effects. In the presen...

Full description

Bibliographic Details
Main Authors: Violina T. Angelova, Teodora Tatarova, Rositsa Mihaylova, Nikolay Vassilev, Boris Petrov, Zvetanka Zhivkova, Irini Doytchinova
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Molecules
Subjects:
sulfonyl hydrazones
MCF-7
MDA-MB-231
QSAR
breast cancer
anticancer activity
Online Access:https://www.mdpi.com/1420-3049/28/5/2058

Similar Items

Similar Items